Advertisement
Original Article| Volume 166, ISSUE 6, P706-720.e11, December 2015

Download started.

Ok

MicroRNA expression profiles differentiate chronic pain condition subtypes

      Chronic pain is a significant health care problem, ineffectively treated because of its unclear etiology and heterogeneous clinical presentation. Emerging evidence demonstrates that microRNAs (miRNAs) regulate the expression of pain-relevant genes, yet little is known about their role in chronic pain. Here, we evaluate the relationship among pain, psychological characteristics, plasma cytokines, and whole blood miRNAs in 22 healthy controls (HCs); 33 subjects with chronic pelvic pain (vestibulodynia, VBD); and 23 subjects with VBD and irritable bowel syndrome (VBD + IBS). VBD subjects were similar to HCs in self-reported pain, psychological profiles, and remote bodily pain. VBD + IBS subjects reported decreased health and function; and an increase in headaches, somatization, and remote bodily pain. Furthermore, VBD subjects exhibited a balance in proinflammatory and anti-inflammatory cytokines, whereas VBD + IBS subjects failed to exhibit a compensatory increase in anti-inflammatory cytokines. VBD subjects differed from controls in expression of 10 miRNAs of predicted importance for pain and estrogen signaling. VBD + IBS subjects differed from controls in expression of 11 miRNAs of predicted importance for pain, cell physiology, and insulin signaling. miRNA expression was correlated with pain-relevant phenotypes and cytokine levels. These results suggest that miRNAs represent a valuable tool for differentiating VBD subtypes (localized pain with apparent peripheral neurosensory disruption vs widespread pain with a central sensory contribution) that may require different treatment approaches.

      Abbreviations:

      CCPC (complex chronic pain condition), CNS (central nervous system), FM (fibromyalgia), HC (healthy controls), IBS (irritable bowel syndrome), IL-1ra (interleukin 1 receptor antagonist), IL-8 (interleukin 8), miRNAs (microRNAs), TMD (temporomandibular disorder), TMJ (temporomandibular joint), VBD (vestibulodynia)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zolnoun D.A.
        • Rohl J.
        • Moore C.G.
        • Perinetti-Liebert C.
        • Lamvu G.M.
        • Maixner W.
        Overlap between orofacial pain and vulvar vestibulitis syndrome.
        Clin J Pain. 2008; 24: 187-191
        • Wesselmann U.
        • Bonham A.
        • Foster D.
        Vulvodynia: current state of the biological science.
        Pain. 2014; 155: 1696-1701
        • Williams R.E.
        • Hartmann K.E.
        • Sandler R.S.
        • Miller W.C.
        • Steege J.F.
        Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain.
        Obstet Gynecol. 2004; 104: 452-458
        • Brennan F.
        • Carr D.B.
        • Cousins M.
        Pain management: a fundamental human right.
        Anesth Analg. 2007; 105: 205-221
        • Diatchenko L.
        • Nackley A.G.
        • Slade G.D.
        • Fillingim R.B.
        • Maixner W.
        Idiopathic pain disorders—pathways of vulnerability.
        Pain. 2006; 123: 226-230
        • Slade G.D.
        • Conrad M.S.
        • Diatchenko L.
        • et al.
        Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness.
        Pain. 2011; 152: 2802-2812
        • Bartel D.P.
        MicroRNAs: target recognition and regulatory functions.
        Cell. 2009; 136: 215-233
        • Niederberger E.
        • Kynast K.
        • Lotsch J.
        • Geisslinger G.
        MicroRNAs as new players in the pain game.
        Pain. 2011; 152: 1455-1458
        • Orlova I.A.
        • Alexander G.M.
        • Qureshi R.A.
        • et al.
        MicroRNA modulation in complex regional pain syndrome.
        J Transl Med. 2011; 9: 195
        • O'Connor R.M.
        • Dinan T.G.
        • Cryan J.F.
        Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression.
        Mol Psychiatry. 2012; 17: 359-376
        • Dai R.
        • Ahmed S.A.
        MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases.
        Transl Res. 2011; 157: 163-179
        • von Schack D.
        • Agostino M.J.
        • Murray B.S.
        • et al.
        Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain.
        PLoS One. 2011; 6: e17670
        • Borgonio Cuadra V.M.
        • Gonzalez-Huerta N.C.
        • Romero-Cordoba S.
        • Hidalgo-Miranda A.
        • Miranda-Duarte A.
        Altered expression of circulating microRNA in plasma of patients with primary osteoarthritis and in silico analysis of their pathways.
        PLoS One. 2014; 9: e97690
        • Iliopoulos D.
        • Malizos K.N.
        • Oikonomou P.
        • Tsezou A.
        Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks.
        PLoS One. 2008; 3: e3740
        • Zolnoun D.
        • Bair E.
        • Essick G.
        • Gracely R.
        • Goyal V.
        • Maixner W.
        Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis.
        J Pain. 2012; 13: 910-920
        • Pukall C.F.
        • Binik Y.M.
        • Khalife S.
        A new instrument for pain assessment in vulvar vestibulitis syndrome.
        J Sex Marital Ther. 2004; 30: 69-78
        • Thompson W.G.
        • Longstreth G.F.
        • Drossman D.A.
        • Heaton K.W.
        • Irvine E.J.
        • Muller-Lissner S.A.
        Functional bowel disorders and functional abdominal pain.
        Gut. 1999; 45: II43-II47
        • Wolfe F.
        • Clauw D.J.
        • Fitzcharles M.A.
        • et al.
        The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.
        Arthritis Care Res. 2010; 62: 600-610
        • Dworkin S.F.
        Research diagnostic criteria for temporomandibular disorders: current status & future relevance.
        J Oral Rehabil. 2010; 37: 734-743
        • Olesen J.
        The International Classification of Headache Disorders, 2nd edition: application to practice.
        Funct Neurol. 2005; 20: 61-68
        • Price D.D.
        • Hu J.W.
        • Dubner R.
        • Gracely R.H.
        Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses.
        Pain. 1977; 3: 57-68
        • Gandek B.
        • Ware J.E.
        • Aaronson N.K.
        • et al.
        Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.
        J Clin Epidemiol. 1998; 51: 1171-1178
        • Ohrbach R.
        • Fillingim R.B.
        • Mulkey F.
        • et al.
        Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.
        J Pain. 2011; 12: T27-T45
        • Kennedy B.L.
        • Morris R.L.
        • Pedley L.L.
        • Schwab J.J.
        The ability of the Symptom Checklist SCL-90 to differentiate various anxiety and depressive disorders.
        Psychiatr Q. 2001; 72: 277-288
        • Chapman C.R.
        • Tuckett R.P.
        • Song C.W.
        Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions.
        J Pain. 2008; 9: 122-145
        • Sullivan P.F.
        • Fan C.
        • Perou C.M.
        Evaluating the comparability of gene expression in blood and brain.
        Am J Med Genet B Neuropsychiatr Genet. 2006; 141: 261-268
        • Zeng L.
        • Liu J.
        • Wang Y.
        • et al.
        MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia.
        Front Biosci. 2011; 3: 1265-1272
        • Mestdagh P.
        • Van Vlierberghe P.
        • De Weer A.
        • et al.
        A novel and universal method for microRNA RT-qPCR data normalization.
        Genome Biol. 2009; 10: R64
        • Huber W.
        • von Heydebreck A.
        • Sultmann H.
        • Poustka A.
        • Vingron M.
        Variance stabilization applied to microarray data calibration and to the quantification of differential expression.
        Bioinformatics. 2002; 18: S96-S104
        • Vlachos I.S.
        • Kostoulas N.
        • Vergoulis T.
        • et al.
        DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways.
        Nucleic Acids Res. 2012; 40: W498-W504
        • Lang R.
        • Hammer M.
        • Mages J.
        DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response.
        J Immunol. 2006; 177: 7497-7504
        • Zolnoun D.
        • Hartmann K.
        • Lamvu G.
        • As-Sanie S.
        • Maixner W.
        • Steege J.
        A conceptual model for the pathophysiology of vulvar vestibulitis syndrome.
        Obstet Gynecol Surv. 2006; 61 (quiz 23): 395-401
        • Woolf C.J.
        Central sensitization: implications for the diagnosis and treatment of pain.
        Pain. 2011; 152: S2-S15
        • Slade G.D.
        • Smith S.B.
        • Zaykin D.V.
        • et al.
        Facial pain with localized and widespread manifestations: separate pathways of vulnerability.
        Pain. 2013; 154: 2335-2343
        • Gracely R.H.
        • Grant M.A.
        • Giesecke T.
        Evoked pain measures in fibromyalgia.
        Best Pract Res Clin Rheumatol. 2003; 17: 593-609
        • Pfau D.B.
        • Rolke R.
        • Nickel R.
        • Treede R.D.
        • Daublaender M.
        Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and fibromyalgia syndrome.
        Pain. 2009; 147: 72-83
        • Kaneyama K.
        • Segami N.
        • Nishimura M.
        • Suzuki T.
        • Sato J.
        Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders.
        Br J Oral Maxillofac Surg. 2002; 40: 418-423
        • Bazzichi L.
        • Rossi A.
        • Massimetti G.
        • et al.
        Cytokine patterns in fibromyalgia and their correlation with clinical manifestations.
        Clin Exp Rheumatol. 2007; 25: 225-230
        • Hattar K.
        • Fink L.
        • Fietzner K.
        • et al.
        Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
        J Immunol. 2001; 166: 6287-6293
        • Schwarz Y.A.
        • Amin R.S.
        • Stark J.M.
        • Trapnell B.C.
        • Wilmott R.W.
        Interleukin-1 receptor antagonist inhibits interleukin-8 expression in A549 respiratory epithelial cells infected in vitro with a replication-deficient recombinant adenovirus vector.
        Am J Respir Cell Mol Biol. 1999; 21: 388-394
        • He N.
        • Zheng H.
        • Li P.
        • et al.
        miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.
        PLoS One. 2014; 9: e102093
        • Zaman M.S.
        • Maher D.M.
        • Khan S.
        • Jaggi M.
        • Chauhan S.C.
        Current status and implications of microRNAs in ovarian cancer diagnosis and therapy.
        J Ovarian Res. 2012; 5: 44
        • Nishimura M.
        • Jung E.J.
        • Shah M.Y.
        • et al.
        Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.
        Cancer Discov. 2013; 3: 1302-1315
        • Satoh J.
        • Kino Y.
        • Niida S.
        MicroRNA-Seq data analysis pipeline to identify blood biomarkers for Alzheimer's disease from public data.
        Biomark Insights. 2015; 10: 21-31
        • Burgos K.
        • Malenica I.
        • Metpally R.
        • et al.
        Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.
        PLoS One. 2014; 9: e94839
        • Keklikoglou I.
        • Koerner C.
        • Schmidt C.
        • et al.
        MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways.
        Oncogene. 2012; 31: 4150-4163
        • Nazarov P.V.
        • Reinsbach S.E.
        • Muller A.
        • et al.
        Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function.
        Nucleic Acids Res. 2013; 41: 2817-2831
        • Horbelt D.
        • Denkis A.
        • Knaus P.
        A portrait of transforming growth factor beta superfamily signalling: background matters.
        Int J Biochem Cell Biol. 2012; 44: 469-474
        • Wang W.
        • Huang X.R.
        • Li A.G.
        • et al.
        Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
        J Am Soc Nephrol. 2005; 16: 1371-1383
        • Ji R.R.
        • Gereau 4th, R.W.
        • Malcangio M.
        • Strichartz G.R.
        MAP kinase and pain.
        Brain Res Rev. 2009; 60: 135-148
        • Wang S.
        • Zhang L.
        • Ma Y.
        • et al.
        Nociceptive behavior following hindpaw burn injury in young rats: response to systemic morphine.
        Pain Med. 2011; 12: 87-98
        • Sun X.
        • Icli B.
        • Wara A.K.
        • et al.
        MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation.
        J Clin Invest. 2012; 122: 1973-1990
        • Kulyte A.
        • Belarbi Y.
        • Lorente-Cebrian S.
        • et al.
        Additive effects of microRNAs and transcription factors on CCL2 production in human white adipose tissue.
        Diabetes. 2014; 63: 1248-1258
        • Itokazu T.
        • Hayano Y.
        • Takahashi R.
        • Yamashita T.
        Involvement of Wnt/beta-catenin signaling in the development of neuropathic pain.
        Neurosci Res. 2014; 79: 34-40
        • Simonetti M.
        • Agarwal N.
        • Stosser S.
        • et al.
        Wnt-Fzd signaling sensitizes peripheral sensory neurons via distinct noncanonical pathways.
        Neuron. 2014; 83: 104-121
        • Mortensen M.M.
        • Hoyer S.
        • Orntoft T.F.
        • Sorensen K.D.
        • Dyrskjot L.
        • Borre M.
        High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy.
        BMC Cancer. 2014; 14: 859
        • Liu X.
        • Feng J.
        • Tang L.
        • Liao L.
        • Xu Q.
        • Zhu S.
        The regulation and function of miR-21-FOXO3a-miR-34b/c signaling in breast cancer.
        Int J Mol Sci. 2015; 16: 3148-3162
        • Lan H.
        • Lu H.
        • Wang X.
        • Jin H.
        MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
        Biomed Res Int. 2015; 2015: 125094
        • Peng Y.
        • Liu Y.M.
        • Li L.C.
        • Wang L.L.
        • Wu X.L.
        MicroRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition.
        Oncol Lett. 2014; 7: 1233-1238
        • Ye F.
        • Tang H.
        • Liu Q.
        • et al.
        MiR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.
        J Transl Med. 2014; 12: 17
        • Chen X.N.
        • Wang K.F.
        • Xu Z.Q.
        • et al.
        MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1.
        Cancer Cell Int. 2014; 14: 70
        • Sanchez Freire V.
        • Burkhard F.C.
        • Kessler T.M.
        • Kuhn A.
        • Draeger A.
        • Monastyrskaya K.
        MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome.
        Am J Pathol. 2010; 176: 288-303
        • Douglas S.D.
        • Leeman S.E.
        Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.
        Ann N Y Acad Sci. 2011; 1217: 83-95
        • Shi L.
        • Wang L.
        • Wang B.
        • et al.
        Regulatory mechanisms of betacellulin in CXCL8 production from lung cancer cells.
        J Transl Med. 2014; 12: 70
        • Dai D.W.
        • Xu Z.
        • Chen X.
        • et al.
        Distinct roles of neuregulin in different models of neuropathic pain.
        Neurol Sci. 2014; 35: 531-536
        • Zhu N.
        • Zhang D.
        • Chen S.
        • et al.
        Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration.
        Atherosclerosis. 2011; 215: 286-293
        • Jaggi A.S.
        • Singh N.
        Intrathecal delivery of farnesyl thiosalicylic acid and GW 5074 attenuates hyperalgesia and allodynia in chronic constriction injury-induced neuropathic pain in rats.
        Neurol Sci. 2013; 34: 297-304
        • Quinn S.R.
        • Mangan N.E.
        • Caffrey B.E.
        • et al.
        The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10.
        J Biol Chem. 2014; 289: 4316-4325
        • Ji H.
        • Houghton A.M.
        • Mariani T.J.
        • et al.
        K-ras activation generates an inflammatory response in lung tumors.
        Oncogene. 2006; 25: 2105-2112
        • McCullough S.D.
        • Duncan K.E.
        • Swanton S.M.
        • Dailey L.A.
        • Diaz-Sanchez D.
        • Devlin R.B.
        Ozone induces a pro-inflammatory response in primary human bronchial epithelial cells through MAP kinase activation without NF-kappaB activation.
        Am J Respir Cell Mol Biol. 2014; 51: 426-435
        • Miyagawa S.
        • Katsu Y.
        • Watanabe H.
        • Iguchi T.
        Estrogen-independent activation of erbBs signaling and estrogen receptor alpha in the mouse vagina exposed neonatally to diethylstilbestrol.
        Oncogene. 2004; 23: 340-349
        • Kalet B.T.
        • Anglin S.R.
        • Handschy A.
        • et al.
        Transcription factor Ets1 cooperates with estrogen receptor alpha to stimulate estradiol-dependent growth in breast cancer cells and tumors.
        PLoS One. 2013; 8: e68815
        • Pratt M.A.
        • Satkunaratnam A.
        • Novosad D.M.
        Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells.
        Mol Cell Biochem. 1998; 189: 119-125
        • Aupperlee M.D.
        • Zhao Y.
        • Tan Y.S.
        • et al.
        Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.
        Endocrinology. 2014; 155: 2301-2313
        • Horii J.
        • Hiraoka S.
        • Kato J.
        • et al.
        Methylation of estrogen receptor 1 in colorectal adenomas is not age-dependent, but is correlated with K-ras mutation.
        Cancer Sci. 2009; 100: 1005-1011
        • Radovick S.
        • Levine J.E.
        • Wolfe A.
        Estrogenic regulation of the GnRH neuron.
        Front Endocrinol. 2012; 3: 52
        • Zhu Y.
        • Sullivan L.L.
        • Nair S.S.
        • et al.
        Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells.
        Cancer Res. 2006; 66: 7991-7998
        • Tanabe E.
        • Shibata A.
        • Inoue S.
        • Kitayoshi M.
        • Fukushima N.
        • Tsujiuchi T.
        Regulation of cell motile activity through the different induction of LPA receptors by estrogens in liver epithelial WB-F344 cells.
        Biochem Biophys Res Commun. 2012; 428: 105-109
        • Practice Committee of the American Society for Reproductive Medicine
        Treatment of pelvic pain associated with endometriosis.
        Fertil Steril. 2006; 86: S18-S27
        • Bazin S.
        • Lefebvre J.
        • Fortier M.
        • et al.
        Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial.
        J Obstet Gynaecol Can. 2011; 33: 838-843
        • Haj-Ahmad T.A.
        • Abdalla M.A.
        • Haj-Ahmad Y.
        Potential urinary miRNA biomarker candidates for the accurate detection of prostate cancer among benign prostatic hyperplasia patients.
        J Cancer. 2014; 5: 182-191
        • Ito T.
        • Sato F.
        • Kan T.
        • et al.
        Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
        Int J Cancer. 2011; 129: 2134-2146
        • Shigehara K.
        • Yokomuro S.
        • Ishibashi O.
        • et al.
        Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer.
        PLoS One. 2011; 6: e23584
        • Pereira P.M.
        • Marques J.P.
        • Soares A.R.
        • Carreto L.
        • Santos M.A.
        MicroRNA expression variability in human cervical tissues.
        PLoS One. 2010; 5: e11780
        • Ninio-Many L.
        • Grossman H.
        • Levi M.
        • et al.
        MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells.
        Oncoscience. 2014; 1: 250-261
        • Vetter G.
        • Saumet A.
        • Moes M.
        • et al.
        miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting nectin-1 and StarD10 messengers.
        Oncogene. 2010; 29: 4436-4448
        • Lam W.Y.
        • Yeung A.C.
        • Ngai K.L.
        • et al.
        Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cells.
        BMC Microbiol. 2013; 13: 104
        • Dominguez F.
        • Moreno-Moya J.M.
        • Lozoya T.
        • et al.
        Embryonic miRNA profiles of normal and ectopic pregnancies.
        PLoS One. 2014; 9: e102185
        • Hewagama A.
        • Gorelik G.
        • Patel D.
        • et al.
        Overexpression of X-linked genes in T cells from women with lupus.
        J Autoimmun. 2013; 41: 60-71
        • Dong Y.
        • Li P.
        • Ni Y.
        • Zhao J.
        • Liu Z.
        Decreased microRNA-125a-3p contributes to upregulation of p38 MAPK in rat trigeminal ganglions with orofacial inflammatory pain.
        PLoS One. 2014; 9: e111594
        • Frantz C.
        • Stewart K.M.
        • Weaver V.M.
        The extracellular matrix at a glance.
        J Cell Sci. 2010; 123: 4195-4200
        • Dina O.A.
        • Parada C.A.
        • Yeh J.
        • Chen X.
        • McCarter G.C.
        • Levine J.D.
        Integrin signaling in inflammatory and neuropathic pain in the rat.
        Eur J Neurosci. 2004; 19: 634-642
        • Kim B.
        • Feldman E.L.
        Insulin resistance in the nervous system.
        Trends Endocrinol Metab. 2012; 23: 133-141
        • Calura E.
        • Cagnin S.
        • Raffaello A.
        • Laveder P.
        • Lanfranchi G.
        • Romualdi C.
        Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages.
        BMC Genomics. 2008; 9: 630
        • Schwander M.
        • Shirasaki R.
        • Pfaff S.L.
        • Muller U.
        Beta1 integrins in muscle, but not in motor neurons, are required for skeletal muscle innervation.
        J Neurosci. 2004; 24: 8181-8191
        • Dimitriadis G.
        • Mitrou P.
        • Lambadiari V.
        • Maratou E.
        • Raptis S.A.
        Insulin effects in muscle and adipose tissue.
        Diabetes Res Clin Pract. 2011; 93: S52-S59
        • Luo J.
        • Sobkiw C.L.
        • Hirshman M.F.
        • et al.
        Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia.
        Cell Metab. 2006; 3: 355-366
        • Stenzel D.
        • Lundkvist A.
        • Sauvaget D.
        • et al.
        Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis.
        Development. 2011; 138: 4451-4463
        • Lei W.L.
        • Xing S.G.
        • Deng C.Y.
        • Ju X.C.
        • Jiang X.Y.
        • Luo Z.G.
        Laminin/beta1 integrin signal triggers axon formation by promoting microtubule assembly and stabilization.
        Cell Res. 2012; 22: 954-972
        • Saito F.
        • Moore S.A.
        • Barresi R.
        • et al.
        Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization.
        Neuron. 2003; 38: 747-758
        • Zhou Q.
        • Verne G.N.
        miRNA-based therapies for the irritable bowel syndrome.
        Expert Opin Biol Ther. 2011; 11: 991-995
        • Zhou Q.
        • Souba W.W.
        • Croce C.M.
        • Verne G.N.
        MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.
        Gut. 2010; 59: 775-784
        • Goetsch M.F.
        Unprovoked vestibular burning in late estrogen-deprived menopause: a case series.
        J Low Genit Tract Dis. 2012; 16: 442-446
        • Jeon Y.
        • Kim Y.
        • Shim B.
        • et al.
        A retrospective study of the management of vulvodynia.
        Korean J Urol. 2013; 54: 48-52
        • Ventolini G.
        • Barhan S.
        • Duke J.
        Vulvodynia, a step-wise therapeutic prospective cohort study.
        J Obstet Gynaecol. 2009; 29: 648-650
        • Harris G.
        • Horowitz B.
        • Borgida A.
        Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked.
        J Reprod Med. 2007; 52: 103-106